pillbase.ru

ALECENSA

Active substance: alectinib

CAPSULE · ALECTINIB HYDROCHLORIDE 150 mg/1

United StatesActive

Marketing holder: Genentech, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 3
  • Алектиниб-АМЕДАРТ
    капсулы, 150 мг (original in Russian, GRLS)
    ЛП-№(012550)-(РГ-RU)
    ООО "АМЕДАРТ"
  • Алеценза®
    капсулы, 150 мг (original in Russian, GRLS)
    ЛП-№(000150)-(РГ-RU)
    Ф.Хоффманн-Ля Рош Лтд
  • АЛЕЦЕНЗА®
    капсулы, 150 мг (original in Russian, GRLS)
    ЛП-005109
    Ф. Хоффманн-Ля Рош Лтд.
EU 1
  • Alecensa
    alectinib hydrochloride
    EMEA/H/C/004164
    Roche Registration GmbH
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-33f4-7f65-984b-0a5bff83c41b,01a120c3-ce27-7ece-a8a7-bae401ca3d12,01a120c5-24f1-79b5-991f-3b0f4c251f0f;count=3 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-3060-7c9c-8262-e38ff629e5de,01a1209a-bc05-74e9-8025-0626d44e2760;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50242-130
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 50242-130 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50242-130 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50242-130 · Verified 2026-10-09 · open in source